Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 2
1960 3
1961 3
1962 7
1963 14
1964 11
1965 11
1966 10
1967 18
1968 15
1969 21
1970 39
1971 23
1972 20
1973 25
1974 35
1975 38
1976 41
1977 39
1978 55
1979 39
1980 53
1981 62
1982 59
1983 66
1984 79
1985 84
1986 74
1987 88
1988 90
1989 100
1990 96
1991 80
1992 101
1993 83
1994 96
1995 128
1996 131
1997 134
1998 155
1999 149
2000 163
2001 182
2002 165
2003 172
2004 188
2005 218
2006 210
2007 209
2008 216
2009 231
2010 240
2011 270
2012 296
2013 263
2014 295
2015 307
2016 315
2017 324
2018 352
2019 374
2020 393
2021 409
2022 393
2023 353
2024 418
2025 408
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,995 results

Results by year

Filters applied: . Clear all
Page 1
Future Applications of Cardiothoracic CT.
Schiebler ML, Jinzaki M, Yanagawa M, Pourmorteza A, Yamada Y, Kato Y, Wada N, Schaefer-Prokop C, Dousset V, Tomiyama N, Prokop M, Lima JA, Hatabu H. Schiebler ML, et al. Among authors: kato y. Radiology. 2025 Jun;315(3):e240085. doi: 10.1148/radiol.240085. Radiology. 2025. PMID: 40492912 Review.
Resistance exercise has an antihypertensive effect comparable to that of aerobic exercise in hypertensive patients: a meta-analysis of randomized controlled trials.
Morita H, Abe M, Suematsu Y, Uehara Y, Koyoshi R, Fujimi K, Ideishi A, Takata K, Kato Y, Hirata T, Yahiro E, Morito N, Kitajima K, Satoh A, Yoshimura C, Ishida S, Okutsu S, Takahashi K, Shinohara Y, Sakaguchi T, Katsuki S, Tada K, Fujii T, Funakoshi S, Hu Y, Satoh T, Ohnishi H, Okamura K, Mizuno H, Arakawa K, Asayama K, Ohtsubo T, Ishigami T, Shibata S, Fujita T, Munakata M, Ohishi M, Ichihara A, Katsuya T, Mukoyama M, Rakugi H, Node K, Arima H, Miura SI. Morita H, et al. Among authors: kato y. Hypertens Res. 2025 Feb;48(2):733-743. doi: 10.1038/s41440-024-01998-9. Epub 2024 Nov 28. Hypertens Res. 2025. PMID: 39609644
Single-cell analysis reveals immune cell abnormalities underlying the clinical heterogeneity of patients with systemic sclerosis.
Shimagami H, Nishimura K, Matsushita H, Metsugi S, Kato Y, Kawasaki T, Tsujimoto K, Edahiro R, Itotagawa E, Naito M, Kawada S, Nakatsubo D, Matsukawa K, Namba-Hamano T, Inoue K, Takahashi A, Mizui M, Kato S, Hikita H, Nakazawa S, Kakuta Y, Konaka H, Mitsumoto K, Ishikawa N, Fujimoto J, Higa S, Omiya R, Isaka Y, Takehara T, Nonomura N, Okada Y, Hattori K, Narazaki M, Kumanogoh A, Nishide M. Shimagami H, et al. Among authors: kato y. Nat Commun. 2025 Jun 17;16(1):4949. doi: 10.1038/s41467-025-60034-7. Nat Commun. 2025. PMID: 40527894 Free PMC article.
ULK1-regulated AMP sensing by AMPK and its application for the treatment of chronic kidney disease.
Yanagi T, Kikuchi H, Takeuchi K, Susa K, Mori T, Chiga M, Yamamoto K, Furukawa A, Kanazawa T, Kato Y, Takahashi N, Suzuki T, Mori Y, Carter BC, Mori M, Nakano Y, Fujiki T, Hara Y, Suzuki S, Ando F, Mandai S, Honda S, Torii S, Shimizu S, Tanaka H, Fujii Y, Rai T, Uchida S, Sohara E. Yanagi T, et al. Among authors: kato y. Kidney Int. 2024 Nov;106(5):887-906. doi: 10.1016/j.kint.2024.08.024. Kidney Int. 2024. PMID: 39428173 Free article.
Deciphering state-dependent immune features from multi-layer omics data at single-cell resolution.
Edahiro R, Sato G, Naito T, Shirai Y, Saiki R, Sonehara K, Tomofuji Y, Yamamoto K, Namba S, Sasa N, Nagao G, Wang QS, Takahashi Y, Hasegawa T, Kishikawa T, Suzuki K, Liu YC, Motooka D, Takuwa A, Tanaka H, Azekawa S; Japan COVID-19 Task Force; Namkoong H, Koike R, Kimura A, Imoto S, Miyano S, Kanai T, Fukunaga K, Uemura M, Morita T, Kato Y, Hirata H, Takeda Y, Doki Y, Eguchi H, Okuzaki D, Sakakibara S, Ogawa S, Kumanogoh A, Okada Y. Edahiro R, et al. Among authors: kato y. Nat Genet. 2025 Aug;57(8):1905-1921. doi: 10.1038/s41588-025-02266-3. Epub 2025 Jul 28. Nat Genet. 2025. PMID: 40721531 Free PMC article.
Responders and non-responders to romosozumab treatment.
Tominaga A, Wada K, Kato Y, Okazaki K. Tominaga A, et al. Among authors: kato y. J Bone Miner Metab. 2025 Jan;43(1):18-21. doi: 10.1007/s00774-024-01570-y. Epub 2024 Dec 7. J Bone Miner Metab. 2025. PMID: 39645533 Review.
Efficacy of immune checkpoint inhibitors plus platinum-based chemotherapy as 1st line treatment for patients with non-small cell lung cancer harboring HER2 mutations: Results from LC-SCRUM-Asia.
Kato Y, Udagawa H, Matsumoto S, Izumi H, Ohe Y, Kato T, Nishino K, Miyamoto S, Kawana S, Chikamori K, Shingyoji M, Sato Y, Takada Y, Toyozawa R, Azuma K, Tanaka Y, Sakai T, Shibata Y, Sugiyama E, Nosaki K, Zenke Y, Umemura S, Yoh K, Seike M, Goto K. Kato Y, et al. Lung Cancer. 2024 Nov;197:107992. doi: 10.1016/j.lungcan.2024.107992. Epub 2024 Oct 13. Lung Cancer. 2024. PMID: 39423763
Preferential tumor targeting of HER2 by iPSC-derived CAR T cells engineered to overcome multiple barriers to solid tumor efficacy.
Hosking MP, Shirinbak S, Omilusik K, Chandra S, Kaneko MK, Gentile A, Yamamoto S, Shrestha B, Grant J, Boyett M, Cardenas D, Keegan H, Ibitokou S, Pavon C, Mizoguchi T, Ihara T, Nakayama D, Abujarour R, Lee TT, Clarke R, Goodridge J, Peralta E, Maeda T, Takagi J, Arimori T, Kato Y, Valamehr B. Hosking MP, et al. Among authors: kato y. Cell Stem Cell. 2025 Jul 3;32(7):1087-1101.e4. doi: 10.1016/j.stem.2025.05.007. Epub 2025 Jun 4. Cell Stem Cell. 2025. PMID: 40472844
8,995 results